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ABSTRACT
Mulan is an E3 ubiquitin ligase and an E3 SUMO ligase embedded in the outer
mitochondrial membrane. Mulan plays a major role in various cell processes including cell growth,
mitophagy, apoptosis, and mitochondrial dynamics. In addition, its deregulation is involved in the
development and progression of several human disorders such as neurodegeneration, and heart
disease. There are two main discernible domains in Mulan: a large cytoplasmic domain that
encodes the RING-finger motif and carries out the catalytic activity of the protein; the second
domain of Mulan is exposed to the intermembrane space of mitochondria, and its function remains
unknown. This part of Mulan is also referred to as the BAM domain and is expected to have a
significant function since its amino acid sequence has been conserved through evolution and is
found in bacteria, animals, and plants. The purpose of this study is to isolate and characterize
potential binding partner proteins of the BAM domain using the yeast two-hybrid system. These
studies are expected to provide new information on the physiological function of this domain and
how it is potentially used to modulate the ligase activity of Mulan.
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CHAPTER ONE: INTRODUCTION AND REVIEW OF LITERATURE

Mitochondrial ubiquitin ligase activator of NF-κB (Mulan) (W. Li et al., 2008), growth
inhibition and death E3 ligase (GIDE) (B. Zhang et al., 2008), mitochondrial-anchored protein
ligase (MAPL) (Neuspiel et al., 2008), Hades (J. H. Jung et al., 2011), RNF218, C1orf166, and
Mitochondrial ubiquitin ligase 1 (MUL1) are all names for the same protein that is a regulator of
several key cellular processes. Mulan is expressed ubiquitously but higher expression is found in
the placenta, liver, kidney, and heart. Intracellularly, Mulan protein is localized in peroxisomes
and mitochondria as a homo-dimer embedded membrane protein (Braschi et al., 2010; B. Zhang
et al., 2008). Mulan crosses the outer mitochondrial membrane (OMM) twice with a BAM
domain that faces the intermembrane space (IMS) of the mitochondria (figure 1). The function of
this domain is unknown; however, the BAM domain is conserved in a wide variety of bacteria
and across holozoan and viridiplantae lineages. BAM is suggested to originate from a common
ancestor rather than independent horizontal gene transfers from bacteria (Wideman & Moore,
2015). The C-terminal RING finger domain of Mulan faces the cytosol and is responsible for the
E3 ubiquitin and E3 SUMO ligase activity of Mulan (Braschi, Zunino, & McBride, 2009; W. Li
et al., 2008; B. Zhang et al., 2008). Through this mechanism, Mulan has been shown to play a
role in various cell processes such as mitochondrial dynamics, apoptosis, and mitophagy (Yun et
al., 2014).
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Figure 1: Mulan and the Ubiquitin Proteasome Pathway

A. Diagram of Mulan and location of the BAM domain. B. The ubiquitin proteasome pathway
(UPP) uses a ubiquitin activating enzyme (E1), ubiquitin conjugating enzyme (E2) and a
ubiquitin ligating enzyme (E3) to tag proteins with ubiquitin (Ub) monomers. Further addition of
Ub onto proteins eventually marks proteins for degradation by the 26S proteasome. Specificity of
the UPP depends on a great variety of E3 ligases compared to the number of E1 and E2 enzymes
(Graham & Liu, 2016). Mulan is an E3 ubiquitin as well as SUMO ligase.
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1.1 Mitochondrial Dynamics

Mitochondria are the powerhouses of the cell and a key center for other metabolic
activities such as Ca2+ homeostasis and apoptosis (Bohovych & Khalimonchuk, 2016). However,
cells do not have a static energy requirement. To meet this varying need for energy,
mitochondria are regulated dynamically. Continuous cycles of fusion and fission change the
appearance and efficiency of the mitochondria. Mitochondrial dynamics not only play a role in
energy regulation and cell cycle progression, but are also involved in quality control of the
mitochondrial population (Horbay & Bilyy, 2016).
Mitochondrial dynamics revolve around the fusion and fission of mitochondria. Fusion is
regulated by Mitofusin 1 (Mfn1) and Mitofusin 2 (Mfn2) for the OMM and by Optic Atrophy 1
(OPA1) in the IMM (Chen et al., 2003; Song, Ghochani, McCaffery, Frey, & Chan, 2009).
Whereas fission is performed by the GTPase Drp1(Braschi et al., 2009). Fission results in
unequal daughter mitochondria one of which is often hyperpolarized while the other is
depolarized. The mitochondrial respiratory chain maintains the mitochondrial membrane
potential (∆Ψm) and therefore disruption of respiration results in membrane depolarization
(Dinkova-Kostova & Abramov, 2015). These dysfunctional, depolarized daughter mitochondria
are characterized by lack of fusion due to reduced OPA1 levels (Twig et al., 2008). OPA1 is
processed from long form (L-OPA1) to short form (S-OPA1) by Yme1L and OMA1, which
become active towards OPA1 upon membrane depolarization (K. Zhang, Li, & Song, 2014).
Mulan was first identified by its ability to cause mitochondrial fragmentation when
overexpressed (Neuspiel et al., 2008). This phenotype was found to be dependent on the RING
3

finger E3 ligase activity and its localization to the outer mitochondrial membrane (W. Li et al.,
2008). Mulan SUMOylates the GTPase Drp1 which stabilizes it, promotes mitochondrial fission
and reduces the rate of fusion (Braschi et al., 2009). Mulan also binds Mitofusion 2 (Mfn2) and
ubiquitinates it thus marking it for degradation which decreases the rate of fusion. Mulan
possibly acts in a parallel pathway as Parkinson’s Disease (PD) gene, parkin, and could
potentially compensate for loss of parkin in some model systems (Cilenti et al., unpublished
work). When both parkin and Mulan were knocked out (KO) in cultured mouse cortical neurons,
the cells displayed reduced ∆Ψm and other signs of neurodegeneration, but if either protein was
KO individually, cells and animals presented phenotypes (Yun et al., 2014)
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Figure 2: Mitochondrial Dynamics

Mitochondrial dynamics are marked by the processes of fission and fusion of mitochondria.
Fission is performed by Drp1 oligomerization and constriction. Fusion is performed by Mfn1,
Mfn2, and Opa1. The Mfn proteins promote tethering and fusion of the OMM whereas Opa1
promotes fusion of the IMM (Dorn & Kitsis, 2014).
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1.2 Apoptosis
Apoptosis is a mechanism of controlled cell death. Two main pathways of cell death
exist; the extrinsic pathway where cell death is initiated by cell-surface death receptors bound to
their ligands or the intrinsic pathway (also known as the mitochondrial pathway) where the
OMM is permeabilized and pro-apoptotic factors are released. Both pathways result in the
activation of the caspase family of proteases which include initiator caspases and executioner
caspases that are responsible for dismantling the cell. Apoptosis causes cell shrinkage, membrane
blebbing, and nuclear condensation (Green & Llambi, 2015).
Activation of the intrinsic pathway involves members of the Bcl2 family of proteins
orchestrating mitochondrial outer membrane permeabilization (MOMP). The Bcl2 family
includes the proapoptotic effectors (Bax and Bak), the antiapoptotic (Bcl2, Bcl-xL, and Mcl1),
and the proapoptotic promoter BH-3 only (Bid, Bim, Bad, and Noxa) proteins. Activation of
Bax/Bak results in their oligomerization into a pore that results in MOMP (Chipuk, Moldoveanu,
Llambi, Parsons, & Green, 2010). The pore allows for the release of proteins stored in the IMS
such as Smac/Diablo, Omi and cytochrome C. The Smac/Diablo and Omi proteases inactivate
the X-linked inhibitor of apoptosis (XIAP) which rescues caspases from inhibition (Eckelman et
al., 2006). Cytochrome C binds to apoptotic protease-activating factor 1 (APAF1) and
oligomerizes into the apoptosome which activates caspase-9. Caspase-9 activates caspase-3 and
caspase-7 which are executioner caspases and apoptosis ensues (Bratton & Salvesen, 2010).
Mulan overexpression is known to induce apoptosis. Twelve hours after transfection,
Mulan-overexpressing cells fragment their DNA, round-up, and detach from the dish in a dose-
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dependent manner. Overexpression of Mulan induces loss of mitochondrial membrane potential
(Δψm) and release of Smac/cytochrome c thus iniating the intrinsic pathway independent of
Bax/Bac pathway (B. Zhang et al., 2008). Mulan also promotes apoptosis by targeting p73 and
p53 for degradation by ubiquitination (J. H. Jung et al., 2011; Min, Ryu, Chi, & Yi, 2015).
The effector mechanism of Mulan in promoting apoptosis has been proposed. Through
SUMOylation, Mulan has also been shown to stabilize Drp1, a dynamin-related GTPase, that is
recruited to the OMM facing the cytosol and is involved in mitochondrial fission. The
SUMOylation of Drp1 by Mulan is downstream of Bax/Bak activation and is required for
apoptosis. Drp1 SUMOylation by Mulan promotes its oligomerization which stabilizes
endoplasmic reticulum (ER)/mitochondrial contact sites and promotes mitochondrial calcium
influx. This calcium influx allows the cristae to remodel and results in cytochrome c release.
Also, SUMOylated Drp1 was shown to recruit active Bax to the ER contact sites so that calcium
influx increases Bax/Bak-dependent cytochrome c release (Braschi et al., 2009).
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Figure 3: ER/Mitochondrial Contact Sites and Apoptosis

Following activation of Bax/Bak, Mulan SUMOylates the GTPase Drp1 which stabilizes its
oligomerzation. Drp1 constricts the mitochondria and promotes fission and fragmentation. The
constricted mitochondria stabilize ER/mitochondrial contact sites which are tethered together by
Mfn2 present on both organelles. The ER effluxes calcium which enters the mitochondria and
promotes cytochrome c release and apoptosis (Prudent et al., 2015).
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1.3 Mitophagy
Autophagy is the general process of cellular “self-eating”. Dysfunctional or unnecessary
organelles are surrounded by a double-membrane vesicle called an autophagosome. The
autophagosome then fuses with a lysosome to recycle nutrients. While autophagy may be
induced by starvation, other forms of autophagy are more specific and play a protective role (Y.C. Tang, Tian, Yi, & Chen, 2016).
As a subset of autophagy, mitophagy is the targeted removal of mitochondria. Membrane
depolarization targets mitochondria for mitophagy in a mechanism that depends on disruption of
the respiratory chain, but not on ATP levels (Priault et al., 2005). Mitophagy causes a
mitochondrion to fuse with an autophagosome and allow lysosomal digestion of the organelle to
remove damaged pieces and recycle its nutrients (Elmore, Qian, Grissom, & Lemasters, 2001).
Autophagy is regulated in part by calcium. ER-mitochondrial contact points allow for the
release of calcium which enters the IMS via voltage-dependent anion channel 1 (VDAC1) and is
taken up by the mitochondrial calcium uniporter (MCU) into the mitochondrial matrix (Csordás
et al., 2006). Calcium present in the mitochondria promotes oxidative phosphorylation and ATP
synthesis by activating pyruvate-, isocitrate-, and α-ketoglutarate dehydrogenases (Glancy &
Balaban, 2012). Mitochondrial respiration inhibits adenosine monophosphate-activated protein
kinase (AMPK) which is an activator of autophagy (Mihaylova & Shaw, 2011). Impaired
mitochondrial respiration increases production of ROS, such as H2O2, which activate the
autophagy protein ATG4 (Scherz-Shouval et al., 2007). ROS are thought to regulate calcium
oscillations required for efficient mitochondrial respiration (Camello-Almaraz, Gomez-Pinilla,
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Pozo, & Camello, 2006). However, excessive intake of calcium into the mitochondria opens the
mitochondrial permeability transition pore (MPTP) which disrupts the proton gradient and
activates apoptosis or autophagy (Bernardi & Petronilli, 1996; Elmore et al., 2001).
While there is much evidence for the role of calcium in regulating autophagy, researchers
are just beginning to investigate the role of calcium in regulating mitophagy. The classical
pathway of mitophagy is regulated by parkin/PINK1. The ubiquitin ligase parkin is thought to be
recruited to depolarized mitochondria by PINK1 and become docked in VDAC1 where it
promotes mitophagy. Parkin overexpression has been shown to enhance ER/mitochondrial
contact points, promote calcium transfer, and increase ATP production dependent on the
ubiquitin ligase activity of parkin (Calì, Ottolini, Negro, & Brini, 2013). PINK1 impairment has
been shown to cause calcium overload, decreased ∆Ψm, and calcium-dependent activation of
Drp1 which causes mitochondrial fragmentation (Heeman et al., 2011; Sandebring et al., 2009).
Mulan is linked to mitophagy since it ubiquitinates Mfn2 which targets Mfn2 for
destruction and further promotes mitochondrial fission which promotes mitophagy (Attaix et al.,
2012). The expression of Mulan and Mfn2 is controlled by the transcription factor FoxO3 that is
responsible for transcription of autophagy machinery (Lokireddy et al., 2012). The role of Mulan
in mitophagy was characterized in relation to inadequate Omi/HtrA2 activity. Cells lacking
active Omi/HtrA2 show increased levels of Mulan which results in the degradation of Mfn2,
mitochondrial dysfunction, and mitophagy (Cilenti et al., 2014).
Further support that Mulan may regulate mitophagy comes from studying its binding
partners. A yeast two-hybrid screen identified GABARAP as an interactor of the E2 enzyme
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Ube2E3 and the E3 ubiquitin ligase RING finger domain of Mulan. Further investigation
revealed that Mulan contains a LC3-interacting region (LIR) motif, Y-x-x-L, required for
interaction with GABARAP. GABARAP is part of the Atg8 family of autophagy proteins and
this interaction might reveal the role of Mulan in mitophagy (Ambivero, Cilenti, Main, &
Zervos, 2014).
Selenite treatment of cells induces mitophagy dependent on Mulan and ULK1 and
independent of parkin or FUNDC1. Selenite results in ULK1 translocation to mitochondria and
ubiquitin-mediated degradation by Mulan. Treatment with reactive oxygen species scavengers
(ROS) decreased ULK1 degradation which suggests Mulan may sense ROS. Compared to
expression of wild-type Mulan, expression of Mulan mutants C62S and C87S in Mulan
knockdown cells failed to rescue selenite-induced mitophagy which suggests Mulan can mediate
its own mitophagy pathway dependent on its intermembrane space domain (J. Li et al., 2015).
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Figure 4: PINK1/Parkin Pathway of Mitophagy

PINK1/parkin pathway is the classical pathway of mitophagy. PINK1 is attracted to depolarized
mitochondria and phosphorylates Mfn2 which attracts parkin. Parkin is an E3 ubiquitin ligase
that adds ubiquitin molecules to various proteins. The ubiquitin binds to p62 which interacts with
LC3 and promotes formation of the autophagosome (Moyzis, Sadoshima, & Gustafsson, 2015).
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1.4 Regulation of Mulan
1.4a Vps35-mediated degradation
Vps35 and Vps26 interact with Mulan and deliver it to peroxisomes by binding the RING
domain independent of RING domain activity (Braschi et al., 2010). Further characterization of
the interaction between Vps35 and Mulan showed that Vps35 promotes degradation of Mulan.
The half-life of Mulan is normally 4 hours, but cells deficient in Vps35 greatly increased the
half-life of Mulan. shRNA-Mulan suppressed Mulan expression and reduced the loss of Mfn2
and mitochondrial fragmentation. microRNA-Vps35 inhibition resulted in greater colocalization
of Mulan with mitochondria which indicates Vps35 is required to remove Mulan from the
mitochondria (F.-L. Tang et al., 2015).
1.4b Omi-mediated degradation
Omi, also known as HtrA2, is a human serine protease that belongs to a family of high
temperature requirement A (HtrA) proteins. Under normal conditions, it is present in the
mitochondrial IMS where it binds exposed hydrophobic residues of misfolded proteins, cleaves
the toxic, misfolded proteins using its serine protease activity and maintains mitochondrial
homeostasis. The inability of Omi to perform its role under normal conditions promotes
mitochondrial permeability transition (MPT) and dysfunction (Julie M. Jones et al., 2003).
Omi has been shown to degrade Mulan under stress conditions. The interaction between
Omi and Mulan occurs via the BAM domain of Mulan that faces the IMS. H2O2 treatment of
cells expressing Omi resulted in decreased Mulan levels whereas other cell stressors did not.
Cells lacking functional Omi protease and mnd2 mutant mice, which carry inactive Omi
13

protease, show upregulation of Mulan. Treatment of cells with mitophagy-inducing CCCP
resulted in elevated Mulan levels that were especially up-regulated in Omi (-/-) cells. Cells
lacking Omi were also shown to be more susceptible to CCCP-induced mitophagy. The
mechanism for this observation is that increased Mulan levels increases ubiquitination of Mfn2, a
protein involved in mitochondrial fusion, which marks it for destruction. Down-regulation of
Mfn2 promotes mitophagy. As a result, Mulan is a promoter of mitophagy that is regulated by
Omi whose activity is regulated by H2O2 (Cilenti et al., 2014).

1.5 Omi and Mulan in vivo with implications for disease
While in the mitochondrial IMS, Omi serves a pro-survival and anti-apoptotic function.
Inactivation of Omi protease leads to misfolded protein accumulation, oxidative phosphorylation
disruption and reactive oxygen species (ROS) production (Julie M. Jones et al., 2003; Martins et
al., 2004). The pro-survival role of Omi/HtrA2 has been studied using the mnd2 (motor neuron
degeneration 2) mouse model. Mnd2 mice lack functional Omi due to a missense mutation at
Ser276Cys which inhibits protease activity due to limited access to the active site (Julie M. Jones
et al., 2003). Mnd2 mice show an autosomal recessive disorder that results in muscle wasting,
reduced thymus and spleen size, and death before day 40 (J M Jones et al., 1993). Neurological
symptoms appear at day 20 with striatal neuron excitotoxic apoptosis and necrosis beginning at
day 25 (Rathke-Hartlieb et al., 2002). Observation of mnd2 striatal neurons showed signs of
apoptosis and necrosis. Mouse embryonic fibroblast cells (MEFs) that lack Omi activity also
show increased susceptibility to apoptosis and necrosis due to stress-inducing agents indicating
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Omi activity is inversely proportional to stress-induced cell death (Julie M. Jones et al., 2003).
Another mouse model where the Omi gene was knocked out displayed a similar phenotype as
mnd2 mice and supports the centrality of Omi in this model (Martins et al., 2004).
Mnd2 mice rescued by expression of Omi/HtrA2 in the central nervous system (CNS)
showed no signs of neurodegeneration or premature death (Kang et al., 2013). Instead of the
parkinsonian phenotype, the rescued mnd2 mice showed signs of premature aging such as
enlarged heart, hair loss, weight loss, curvature of the spine, and death at a much later time
between 12-17 months (Priault et al., 2005). Lack of Omi in non-neuronal tissues led to increase
in misfolded proteins in mitochondria and to increase in reactive oxygen species (ROS).
Subsequently, mtDNA was found to undergo deletions in the gene for cytochrome c oxidase
(COX), or complex IV in the electron transport chain, which helps to explain the premature
aging phenotype. The mnd2 mice showed increased mitochondrial-targeted autophagy, or
mitophagy, corresponding to the increased mitochondrial dysfunction (Kang et al., 2013).

15

Figure 5: MND2 Mutant Mice

Mnd2 mice lack functional Omi protease. As a result, the mice undergo muscle wasting, reduced
thymus and spleen size, and death before day 40. Mulan levels are elevated in these mice and
may play a role in their phenotype (Cilenti et al., 2014; Rathke-Hartlieb et al., 2002).
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Compared with mnd2 mice, neuron-specific HtrA2 deleted mice showed the same
parkinsonian phenotype with cell death occurring in the striatum, entorhinal cortex, and
cerebellum. Irregular mitochondrial function was likely the cause of apoptosis. OPA1 processing
was detectable as early as day 9 in brain tissue, but was not present in other tissues. No change in
Mfn2 was detected. This corresponded to irregular morphologies in the IMM, but not the OMM.
Lastly, the respiratory chain enzymes, Complex I and Complex II, were both shown to be
downregulated only in the brain regions affected by apoptosis (Patterson et al., 2014).
Vps35 (PARK17) and Omi/HtrA2 (PARK13) are both suggested to regulate Mulan
levels. Mutations in the gene encoding Vps35 results in late-onset, autosomal dominant familial
PD (Vilariño-Güell et al., 2011; Zimprich et al., 2011). Analysis of German PD patients revealed
the G399S mutation and A141S polymorphism both produced mitochondrial dysfunction and
changed morphology (Strauss et al., 2005). Mutation analysis of a Belgian cohort revealed a
mutation in the PDZ domain of Omi/HtrA2 is associated with PD. The same study of PD patients
identified mutations in the 3’ and 5’ regulatory regions may also affect expression levels of
Omi/HtrA2 (Bogaerts et al., 2008). While the previous studies were supported with in vitro and
in vivo models, one large-scale genetic analysis found no statistical contribution of common
Omi/HtrA2 variants towards PD (Julie M. Jones et al., 2003; Kawamoto et al., 2008; Krüger et
al., 2011; Strauss et al., 2005).
The role of Omi deficiency in causing the mnd2 parkinsonian-phenotype may be due to
its interaction with Mulan (Cilenti et al., 2014). The level of Mulan rises in the absence of Omi
and allows for Mulan to signal for mitophagy and/or apoptosis using its E3 ubiquitin ligase
activity. In order to better understand the function of Mulan, this study used the BAM domain of
17

Mulan as a bait to screen an expansive HeLa cDNA library using the yeast two-hybrid system in
order to isolate potential interactors. By isolating and characterizing binding partners of the
BAM domain, we should be able to deduce the function of this part of the Mulan protein. We
expect the BAM domain will be a mediator that transmits signals from inside the mitochondria to
the cytoplasm by regulating the ligase activity of Mulan.
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Figure 6: The Yeast Two-Hybrid System

The LexA-Mulan30-240 fusion protein binds to the upstream activating sequence for the reporter
LacZ gene. The Mulan30-240 bait then attracts an unknown prey protein from a HeLa cDNA
library. The prey protein is fused to an activating domain which promotes transcription of the
reporter LacZ gene. The yeast in the presence of a bait/prey interaction express β-galactosidase
and leucine. On plates containing galactose and X-Gal, yeast colonies expressing β-galactosidase
will appear blue which allows for easy screening of the HeLa cDNA library for binding partners.
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CHAPTER TWO: MATERIALS AND METHODS
2.1 Construction of LexA-Mulan30-240 Bait
2.1a Polymerase Chain Reaction
The following DNA primers were used in the cloning of the BAM domain (amino acids
30-240) of Mulan into pGilda using polymerase chain reaction (PCR).

Primer 1: 5’ Mulan30-240 (EcoRI)
5’ GCG GAA TTC CGG CAG AAG GCC CGG 3’
Primer 2: 3’ Mulan30-240 (XhoI)
5’ CCG CTC GAG CTT CCA GAG CCT GAC GCT CGA 3’

Restriction sites for EcoRI or XhoI, were used to clone the DNA fragment corresponding
to the Mulan BAM encoding sequences from aa 30-240. Each PCR reaction used 20 ng template
DNA, 10 ρM of primer 1 and 2 (eurofins), 5 µl of (10X) PCR buffer + Mg2+ (NEB), 100 µM
dNTPs (Clontech), and 1.5 units of Taq polymerase (Roche Diagnostics Corp.) in dH2O for
usually 20 µl total volume. PCR program: Denature at 98°C for 30 seconds then run 25 cycles.
Cycles consist of 98°C for 30 seconds, X°C, depending on primer Tm, for 30 seconds, 72°C for
X seconds depending on size of target DNA. One final elongation period at 72°C for 7 minutes
then PCR samples held at 6°C.
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2.1b Agarose Gel Electrophoresis
1.5 g agarose (Promega) was added to 100 ml of (1X) TAE (0.04 M Tris-acetate, 0.001
M EDTA). Mixture was microwaved for 2 minutes until agarose was fully dissolved. Solution
was allowed to cool before adding 0.5 µg/µl ethidium bromide. The solution was poured into a
gel tray fixed with proper sized columns. Bubbles were removed with a pipette tip if necessary.
Once solidified, combs were removed from the gel. The gel tray was then rotated in the
electrophoresis apparatus and filled with (1X) TAE buffer until the wells were covered with
buffer.

2.1c Preparation of Samples for Agarose Gel Electrophoresis
Samples of DNA were prepared by combining 1-5 µl DNA with 5 µl of (10X) gel
loading buffer (30% glycerol (Fisher), 2% Orange-G (Sigma), all dissolved in (1X) TAE).
Prepared samples of DNA were placed into the corresponding wells and the GeneRuler1kb plus
DNA ladder (ThermoFisher) was added to estimate the size of the DNA. Electrophoresis ran at
150 V using the FB 105 electrophoresis system (Fisher Biotech) until the dye reached the desired
distance based on the length of the sample. Bands on the gel visualized with UV light in a gel
doc.
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2.1d DNA Precipitation
1/10 sample volume of 3M sodium acetate pH 5.5 and 2 equivalent sample volumes of 30°C 100% EtOH were added to the solution containing DNA to be precipitated then stored at 30°C for a minimum of 20 minutes. Samples were spun at 13,200 rpm in Eppendorf Centrifuge
5415 D for 20 minutes at 4°C. Supernatant was removed using a micropipette and 150 µl 70%
EtOH was added. Samples were spun 13,200 rpm for 5 minutes at room temperature.
Supernatant was removed with micropipette and vacuum spun until samples were dry, roughly
15 minutes. DNA was resuspended in dH2O or TAE for desired concentration.

2.1e Restriction Enzyme Digestion
50 µl DNA (from precipitation), 37 µl dH2O, 10 µl (10X) Restriction Enzyme Buffer
(NEB), 1 µl BSA (NEB), and 1.5 µl restriction enzyme 10U/µl, EcoRI or XhoI (NEB) were
combined and incubated for 1-2 hours for EcoRI or 4 hours for XhoI. After one hour, an
additional 0.5 µl restriction enzyme was added for a total volume of 100 µl. DNA was
precipitated from solution then procedure was repeated with a second restriction enzyme and its
corresponding buffer.

2.1f Ligation
The suggested protocol for the Fast-Link DNA Ligation and Screening Kit (Epicentre
Technologies) was followed. 2 µl of DNA was run in an agarose gel and amount of DNA in 1ul
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of insert and 1 ul of vector were estimated. Amount of DNA used for ligation should have a 2:1
insert to vector ratio and the reaction mixture should consist of X µl vector, Y µl insert, Z µl
water, 1.5 µl (10X) buffer, 1.5 µl ATP, and 1 µl ligase were combined for a total of 15 µl.
Samples were incubated at room temperature for 20 minutes then inactivated at 70°C for 15
minutes. DNA was stored at 4°C.

2.1g Bacterial Transformation
Electro-competent cells were removed from a -80°C freezer and thawed on ice. 50 µl
electro-competent cells were combined with 3-4 µl (0.3-1 µg) DNA in ab electroporation cuvette
(0.2 cm electrode gap (BioRad), incubated on ice for 1 minute, and electroporated with a single
exponential decay pulse of 2.5 kV at 400 Ω in a Gene Pulser (BioRad). 900 ml LB was quickly
added then cells were incubated rotating at 37°C for 1 hour. 100 µl and 250 µl of cells were
plated on AMP LB plates with plastic beads (Fisher) to spread. Plates were incubated at 37°C
overnight.

2.1h Isolation of Plasmid DNA from Bacteria: DNA QIAprep Spin Miniprep

The suggested protocol for Plasmid DNA Purification using the QIAprep Spin Miniprep
Kit (QIAgen) was followed. A single bacterial colony was selected and grown shaking in 1.5 ml
AMP LB at 37°C overnight. The bacteria were poured into a 1.5 ml Eppendorf tube and
centrifuged at 13,200 rpm for 2 minutes. The supernatant was aspirated and the pellet was
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resuspended in 250 µl Buffer P1 which contains RNAse. Next, 250 µl Buffer P2 was added and
the solution was mixed by inversion 4-6 times. 350 µl Buffer N3 was added and the solution was
mixed immediately by inversion 4-6 times. The samples were centrifuged at 13,200 rpm for 10
minutes. The supernatant was transferred to a QIAprep spin column and centrifuged for 1
minute. The flow-through was discarded. The column was washed using 500 µl Buffer PB,
centrifuged for 1 minute, and then the flow-through was discarded. The column was washed with
750 µl Buffer PE, centrifuged for 1 minute, and the flow-through was discarded. The column
was centrifuged for 1 more minute to dry the column. Lastly, the QIAprep spin column was
placed in a new 1.5 ml Eppendorf tube and the column was eluted by incubating the column for
1 minute with 50 µl Buffer EB (10 mM Tris-Cl pH 8.5) before centrifuging for 1 minute.

2.1i Isolation of Plasmid DNA from Bacteria: DNA-Boiling Method Miniprep

Colonies were selected and grown overnight at 37°C in 1.5 ml LB AMP. Cells and media
were poured into 1.5 ml Eppendorf tubes and spun at 13,200 rpm in a Centrifuge 5415 D
(Eppendorf) for 2 minutes at room temperature. Supernatant was aspirated and the bacterial
pellet was resuspended in 300 µl STET/lysozyme (6 mg lysozyme, 8% sucrose, 5% 100X Triton,
50mM Tris-HCl pH8, and 50 mM EDTA) by pipetting up and down using a micropipette
(Pipetman). Samples were boiled for 1 minute then spun at 13,200 rpm for 10 minutes at room
temperature. Using a toothpick, the mucus pellet was removed and 200 µl isopropanol was added
and mixed by inversion. Samples were again spun at 13,200 rpm for 10 minutes at room
temperature. Isopropanol was poured off and pellet was washed with the addition of ice-cold
24

70% EtOH. EtOH was poured off and samples were dried in a Savant Speed Vac. DNA was
resuspended in 50 µl TE and vortexed using a Fisher Vortex Genie 2 in for 2 minutes to
resuspend.

2.1j DNA Sequence Analysis
DNA purified using a miniprep was sent to Genewiz for sequencing.

2.2 Yeast Two-Hybrid Interactions
2.2a Yeast Transformation

50 ml of appropriate medium was inoculated with a single yeast colony and grown
shaking overnight at 30°C. Cells were harvested by centrifugation at 3800 rpm in an Allegra 6R
Centrifuge for 5 minutes and the supernatant was poured out. Cells were washed with 10 ml TE
pH 7.5 (10mM Tris pH 5, 1 mM EDTA pH 8) then harvested by centrifugation at 3800 rpm for 5
minutes and the TE was poured out. Cells were resuspended in 5 ml LA (0.1 M LiAC in TE) and
incubated at 30°C shaking for 2 hours. Cells were harvested by centrifugation at 3000 rpm for 5
minutes and the LA was poured out. Cells were again resuspended in 5 ml LA. 300 µl aliquots of
cells were combined with 1 µl denatured SS DNA and 1 µg DNA for transformation. 700 µl
PEG (50% Peg 4000 in LA) (Sigma) was added to the solution, mixed thoroughly, and cells were
incubated in a 30°C heat bath for 30 minutes. Cells were then heat shocked for 15 minutes at
42°C and cells were collected by centrifugation at 13,200 rpm for 3 minutes. The supernatant
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was aspirated and the pellet was resuspended with 300 µl TE pH 7.5. 100 µl and 200 µl of cells
were plated on U⁻ H⁻ Glucose plates and grown for 2-3 days at 30°C. From these plates,
colonies were selected for creation of a glycerol stock.

2.2b Yeast Drop-Out Medium
Yeast drop-out powders W⁻ , U⁻ , U⁻ H⁻ , U⁻ H⁻ W⁻ and U⁻ H⁻ W⁻ L⁻ were
prepared by withholding the corresponding amino acid from the mixture. Yeast drop-out powder
consisted of the 20 amino acids minus the specific drop out ones (Sigma): 1.2 g uracil, 1.2 g
histidine, 2.4 g tryptophan, 3.6 g leucine, 2.5 g adenine, 1.2 g arginine, 1.2 g methionine, 1.8 g
tyrosine, 1.8 g isoleucine, 1.8 g lysine, 3.0 g phenylalanine, 6.0 g glutamic acid, 6.0 g aspartic
acid, 12 g threonine, 22 g serine, 9.0 g valine combined and stored at room temperature.
Yeast drop-out mediums consist of 1 g dropout powder (Sigma), 3.35 g Yeast Nitrogen
Base (Sigma), 10 g glucose or 10 g galactose and 5.0 g raffinose were dissolved in dH2O for a
total volume of 500 ml. 10 g agar (Apex) was also added if the medium was for plates. The
medium was autoclaved for 40 minute. After autoclaving, the solution was allowed to cool
briefly before adding 50 ml (10X) BU salt and 1 ml X-Gal if the medium was for blue-white
screening. Then the media was poured into many small petri dishes or 24x24 cm plates where it
solidified or kept in a bottle if no agar was added. Bottles were kept at room temperature and
plates were stored at 4°C for several weeks.
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2.2c Yeast SDS-PAGE
For 12% resolving gels, 10 ml water, 8 ml 40% acrylamide mix (BioRad), 6.3 ml 1.5 M
Tris pH 8.8, 250 µl 10% SDS, 250 µl 10% APS, and 10 µl TEMED were combined for a total
volume of 20 ml. For 5% stacking gels, 7.3 ml water, 1.25 ml 40% acrylamide mix (BioRad),
1.25 ml 1.0 M Tris pH 6.8, 100 µl 10% SDS, 100 µl 10% APS, and 10 µl TEMED (Fisher) were
combined for a total volume of 20 ml. Glass plates (BioRad) were thoroughly washed with soap
and water then sprayed with 70% EtOH and allowed to air dry. The 12% gel solution was
dispensed into glass plates, covered with isopropanol, and allowed to solidify for 20 minutes.
The isopropanol was removed by rinsing with water and a 5% stacking gel was added and combs
were set. After solidifying for 20 minutes, the gels were wrapped in paper towels soaked in
water, placed in a Ziploc bag, and stored in a Tupperware container at 4°C for several weeks.
Yeast were grown overnight at 30°C shaking in 1.5 ml U⁻H⁻W glucose media. Cells
centrifuged at 13,200 rpm for 3 minutes at room temperature then the supernatant was poured
off. Cells were resuspended in 1 ml U⁻H⁻W⁻ galactose/raffinose media in order to wash them.
Centrifugation of the cells was repeated and the supernatant was poured off. Cells were
resuspended in 500 µl U⁻H⁻W⁻ galactose/raffinose media then transferred to test tubes
containing 500 µl U⁻ H⁻ galactose/raffinose media for total of 1 ml. Cells were incubated by
rotating for 4 hours at 30°C. Centrifugation of the cells was repeated and the supernatant was
poured off. Cells were transferred to microcentrifuge tubes and boiled for 3 minutes to inactivate
proteases. 0.1 g of 0.2 mm glass beads were added to the cells and cells were vortexed for 2
minutes. 70 µl of EBS (2% SDS, 80 mM Tris pH 6.8, 10% glycerol, 1.5% DTT, and 0.1 mg/ml
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bromophenol blue) was added to the yeast cells and the samples were then boiled for 1 minute.
Samples were spun down for 1 minute at 13,200 rpm in order to collect the debris. The
supernatant was analyzed using SDS-PAGE to check for induction and expression of bait fusion
protein.
Polyacrylamide gels were brought to room temperature, had their combs removed, and
were placed in the Mini PROTEAN 3 Cell (Bio-Rad). The middle of the SDS-PAGE apparatus
was filled completely with running buffer (0.02 M Tris, 0.003 M SDS, 0.19 M glycine, pH 8.3).
Samples were prepared by adding 5 µl (4X) sample buffer (10% β-mercaptoethanol, 6% SDS,
20% glycerol, 1/40 X stacking buffer, and 0.2mg/ml bromophenol blue) and boiling for 5
minutes. Samples were then spun down and 10-20 µl were added to the corresponding lanes on
the gel along with 5 µl precision plus protein standards (BioRad). Samples were run at 20A using
the FB 105 electrophoresis system (Fisher Biotech) until the sample buffer dye collected at the
border of the resolving gel. Then the samples were run at 40 A until the sample buffer dye exited
the gel.

2.2d Yeast Western Blot
A PVDF membrane was activated with 10 ml methanol. 10 ml (5X) TBS buffer and 30
ml dH2O were then mixed into the methanol. SDS-PAGE gels were removed from the glass
plates and, along with blot paper, was placed in the same container as the PVDF membrane and
(1X) transfer buffer. On the Trans-Blot SD Semi-Dry Transfer Cell (BioRad), the following
items were placed in order: blot paper, PVDF membrane, SDS-PAGE gel, and then blot paper
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again. With each additional layer, bubbles were removed. The transfer cell was set to 12 and
allowed to run for at least 45 minutes.
Next, the PVDF membrane was soaked in 2% non-fat milk solution dissolved in TBST
(250 mM Tris pH 8, 1.25 M NaCl, and 0.1% Tween20) for at least 2 hours. The membrane was
incubated overnight at 4°C shaking with the primary antibody, α-LexA-HRP, which binds to the
bait fusion protein or α-HA, which binds to prey fusion protein. The antibody was diluted
1:1,000 or 1:5,000 in 2% milk-TBST. The membrane was then washed with TBST for 15
minutes five times. For membranes incubated with α-HA, the PVDF membrane is incubated with
a goat-α-mouse secondary antibody diluted 1:2,000 in 2% milk-TBST for 1 hour. The
membrane was again washed with TBST for 15 minutes five times. Proteins were visualized
using the chemiluminescence ECL kit (PIERCE). 5 ml enhanced chemiluminescence (ECL)
solution 1 Tris pH 8.5 (luminol, p-coumaric acid) and 5 ml ECL solution 2 Tris pH 8.5 were
combined with 3.2 µl H2O2 before covering the PVDF membrane. PVDF was incubated with
blue sensitive autoradiography film (MIDSCI) for varying amount of time in a dark room before
it was developed in a SRX-101A (Konica).

2.3 Screening a HeLa cDNA Library
2.3a Yeast Two-Hybrid Screen of HeLa cDNA Library
The Mulan intermembrane BAM domain (aa 30-240) cloned into the pGilda vector
served as the bait. This vector is inducible by galactose and allows for the DNA-binding domain
of LexA to be attached to the N-terminus of the BAM domain (aa 30-240). The expression of the
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bait is repressed by the presence of glucose and induced by the presence of galactose in the
media. The resulting plasmid was then transformed into the EGY48 yeast strain. This strain
already has a LEU reporter gene under control of a LexA operator and a plasmid, pSH18-34,
which under the control of 8 LexA operators expresses the LacZ reporter that directs the
synthesis of β-galactosidase for blue-white screening on U⁻ H⁻ W⁻ galactose/raffinose + X-Gal
plates
A HeLa cDNA library was screened for proteins capable of interacting with the Mulan
BAM domain. These prey cDNAs were inserted into the pJG4-5 vector. This vector is inducible
by galactose and allows for the transcription activating domain, SV40 nuclear localization signal,
and hemagglutinin (HA) epitope to be linked to the various prey proteins.
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Figure 7: pSH18-34 Vector

A LacZ reporter plasmid that expresses LacZ under control of 8 LexA operators, making it very
sensitive for detecting interactions, in the minimal GAL1 promoter. Also contains the 2µ origin
which allows replication in yeast, ampR gene encoding ampicillin resistance, and the URA3
selectable marker.
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Figure 8: pGilda Bait Vector

A plasmid that expresses an insert as a fusion protein with the LexA DNA-binding protein under
control of the GAL1 promoter which is repressed by glucose and induced by galactose. Also
contains the 2µ origin which allows replication in yeast, ampR gene encoding ampicillin
resistance, and the HIS3 selectable marker.
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Figure 9: pJG4-5 cDNA Library Vector

A plasmid that expresses cDNA fused to acid blob B42, SV40 nuclear localization sequence
(PPKKKRKVA), and hemagglutinin (HA) epitope under control of the GAL1 inducible
promoter. Also contains the 2µ origin which allows replication in yeast, ampR gene encoding
ampicillin resistance, and the TRP1 selectable marker.

33

2.3b High Efficiency Yeast Transformation

50 ml U⁻ H⁻ glucose media was inoculated with single EGY48 yeast colony containing
pSH18034 and pGilda-MulanBAM, and grown shaking overnight at 30°C. The solution was
diluted to 300 ml so that the OD600nm was 0.1 or less. Cells were grown shaking at 30°C until
OD600nm was equal to 0.9. Cells were then harvested by centrifugation at 3800 rpm for 5 minutes
and supernatant was poured out. Cells were resuspended in 20 ml water then harvested by
centrifugation at 3800 rpm for 5 minutes and water was poured out. Cells were resuspended in
20 ml LA (0.1 M LiAce in TE) then harvested by centrifugation at 3000 rpm for 5 minutes and
LA was poured out. Yeast cells were resuspended in 5 ml LA then aliquoted as 100 µl per 1.5 ml
Eppendorf tube. Aliquots were combined with 10 µl (10 µg) transforming library DNA and 10 µl
(100 µg) denatured SS DNA, and 600 µl of fresh 40% PEG solution. Solution was mixed
thoroughly, incubated in a 30°C water bath for 30 minutes, and then heat shocked at 42°C for 15
minutes. Cells were collected by centrifugation at 13,200 rpm for 20 seconds. The supernatant
was aspirated and the pellet was resuspended with 1 ml water. All 1 ml of cells were then plated
on U⁻ H⁻ W⁻ galactose/raffinose 24x24 cm plates (Nalge Nunc) with glass beads (Fisher).
Plates were sealed with Parafilm and cells were incubated at 30°C for two days.

2.3c Efficiency of Yeast Transformation
In order to estimate the average number of colonies per large plate, the number of yeast
colonies on three 2x2 cm squares was counted. The average of the squares was then multiplied
by 126.6 to represent the number of 2x2 cm squares in one 24x24 cm plate. The previously
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plated yeast cells on U⁻ H⁻ W⁻ galactose/raffinose 24x24 cm plates were incubated at 4C to
harden the agar. Colonies were scraped from the large plates using glass slides then the plates
were washed with 10 ml sterilized water twice. The yeast cells were resuspended in 50 ml Falcon
tubes. Cells were collected by centrifugation at 3800 rpm for 5 minutes. The supernatant was
poured off, the cells were washed with 50 ml sterilized water, and then the cells were collected
by centrifugation at 3800 rpm for 5 minutes. The washing of the cells was repeated before
resuspending the cells in filtered yeast freezing medium (65% glycerol, 0.1M MgSO4, 25 mM
Tris pH 7.4). The library was then aliquoted as 300 µl per centrifuge tube and stored at -80°C.

2.3d Titration
In a 1:50 ratio, 100 µl of library aliquot was added to 5 ml of U⁻ H⁻ W⁻
galactose/raffinose media near an open flame. Cells were incubated shaking at 30°C for 5 hours.
Next, the solution was serially diluted (1:10) such that 100 µl of cell solution was added to 900
µl water 5 times in a row. 100 µl of each dilution was plated on U⁻ H⁻ W⁻ galactose/raffinose
plates, sealed with Parafilm and grown at 30°C for two days. Colonies were counted on the 1:
500,000 or 1:5,000,000 plates and number of colonies multiplied by the corresponding dilution
factor revealed the number of colonies per 100 µl library. This information was used to
determine amount of library to be plated. Cells were then plated on U⁻ H⁻ W⁻ L⁻
galactose/raffinose 24x24 cm plates (Nalge Nunc) with glass beads (Fisher). Plates were sealed
with Parafilm and cells were incubated at 30°C for two days.
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2.3e Screening
After the growth test on U⁻ H⁻ W⁻ L⁻ galactose/raffinose plates, positive colonies that
grew were streaked onto U⁻ H⁻ W⁻ glucose plate. The master plate was sealed with Parafilm
and cells were incubated at 30°C for two days. Next, colonies from the master plate were
streaked onto U⁻ H⁻ W⁻ glucose/X-Gal and U⁻ H⁻ W⁻ galactose/raffinose/X-Gal plates. Blue
colonies on the U⁻ H⁻ W⁻ galactose/raffinose/X-Gal plate is indicative of a positive interaction
between the bait and prey. Positive yeast colonies were selected for release of the pJG4-5
plasmid carrying the positively interacting HeLa cDNA library insert from the yeast.

2.3f Release of Plasmids from Yeast
Selected yeast colonies were grown overnight at 30°C overnight in 1 ml W⁻ Glucose
media. 800 µl of yeast were then centrifuged in a microfuge screw-lid tubes for 1 minute at
13,200 rpm. The supernatant was aspirated and the pellet was resuspended in 200 µl yeast lysis
solution (2% TritonX-100, 1% SDS, 100 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA), 0.3 g
150 µm glass beads (soaked in concentrated nitric acid for 1 hour, washed extensively with
water, then baked until dry) (Sigma), and 200 µl Phenol-cloroform-ioamyl alcohol (25:24:1)
(Sigma). A mini-beadbeater (Biospec) was used for 2 minutes to break the yeast cells. Samples
were centrifuged for 5 minutes at 13,200 rpm so that three distinct layers arose. The top layer
containing the DNA was carefully isolated and the DNA was precipitated as previously
described in section 2.1d.
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2.3g Transformation of Plasmid into KC8
The released plasmids released from the yeast were transformed into KC8 bacteria cells
using the protocol described in section 2.1g. KC8 cells were plated on AMP M9 plates.

2.3h Sequencing of HeLa cDNA Library Positive Interactors
Positively transformed KC8 colonies growing on M9 plates were selected for the
extraction of plasmid using the miniprep protocol described in section 2.1h. These plasmids were
sent for DNA sequencing as described in section 2.1j.

2.3i Retransformation in Yeast
Positive interactors for MulanBAM were transformed into yeast containing pGildaMulanBAM using the protocol for yeast transformation as described in section 2.2a.

2.4 Construction of pJG4-5-Calumenin and pJG4-5-S100A10 Full Length Proteins

2.4a Polymerase Chain Reaction
The following DNA primers were used in the cloning of the interactors of the Mulan
BAM domain (amino acids 30-240). pJG4-5-Calumenin and pJG4-5-S100A10 using PCR.
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Primer 3: 5’ pJG4-5-Calumenin (EcoRI)
5’ GGC GAA TTC ATG GAC CTG CAA CAG TTT CTT 3’
Primer 4: 3’ pJG4-5-Calumenin (XhoI)
5’ CCG CTC GAG TCA GAA CTC ATC ATG CCG T 3’
Primer 3: 5’ pJG4-5-S100A10 (EcoRI)
5’ GGC GAA TTC ATG CCA TCT CAA ATG GAA CAC 3’
Primer 4: 3’ pJG4-5-S100A10 (XhoI)
5’ CCG CTC GAG CTA CTT CTT TCC CTT CTG CTT 3’

Restriction sites for, EcoRI or XhoI, were incorporated into the primers so that the PCR
DNA product encoded the Mulan BAM sequence can be cloned in the corresponding sites of
pJG4-5 vector. PCR was performed as described in section 2.1a except that the PCR program
now had cycles consisting of 98°C for 30 seconds, 56°C, depending on primer Tm, for 30
seconds, 72°C for 30 seconds depending on size of target DNA. The PCR products were digested
with EcoRI and XhoI using the protocol described in section 2.1e. Digested DNA was then
cloned into the pJG4-5 plasmid (Novagen) using the ligation protocol described in section 2.1f.
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CHAPTER THREE: RESULTS
3.1 Cloning and Yeast Expression of LexA-Mulan30-240

The cDNA encoding the BAM domain of Mulan (aa 30-240) was cloned into the pGilda
vector as described in chapter two. The pGilda vector is under the control of the GAL1 promoter
which makes expression of the insert induced in the presence of galactose and repressed by the
presence of glucose. The pGilda vector also allows for expression of a LexA DNA-binding
domain and Mulan30-240 fusion protein. LexA-Mulan30-240 has an estimated molecular weight of
43.5 kDa since the molecular weight of Mulan is ≈ 23.5 kDa and the molecular weight of LexA
DNA-binding domain is ≈ 20 kDa (Figure 10).
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Figure 10: Yeast Expression of pGilda-LexA-Mulan30-240

Western blot showing the expression of the LexA-Mulan30-240 fusion protein. Lane 1: LexA. Lane
2: uninduced clone #2 LexA-Mulan30-240. Lane 3: induced clone #2 LexA-Mulan30-240. Lane 4:
uninduced clone #6 LexA-Mulan30-240. Lane 5: induced clone #6 LexA-Mulan30-240. Future
experiments used clone #6 LexA-Mulan30-240. Uninduced yeast were grown in U⁻H⁻W⁻ glucose
media. Induced yeast cells were grown in U⁻H⁻W⁻ galactose/raffinose media.
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3.2 Screening the HeLa cDNA Library

A cDNA library derived from reverse transcription of mRNA isolated from HeLa cells
was cloned unidirectionally, using EcoRI and XhoI, into the pJG4-5 vector to serve as prey. The
BAM domain of Mulan (aa 30-240) was cloned into the pGilda vector to serve as a bait. The
ability of the bait and prey to interact was screened using two reporter genes. The LexAop-LEU2
gene permits the growth of the yeast in media lacking leucine and the LexAop-LacZ gene
expresses β-galactosidase which can be visualized as blue color on X-Gal plates. Millions of
yeast colonies corresponding to each cDNA in the HeLa library were plated on U⁻H⁻W⁻L⁻
galactose/raffinose 24x24 cm plates for the growth test. Several colonies grew which were then
streaked onto U⁻H⁻W⁻ glucose + X-Gal plates and U⁻H⁻W⁻ galactose/raffinose + X-Gal plates.
Six colonies past both tests (Figure 11).
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Figure 11: HeLa cDNA Library Screening

Six potential yeast colonies showing a positive interaction phenotype were streaked onto
U⁻ H⁻ W⁻ galactose/raffinose/X-Gal plates along with a negative control. Blue color in six of
them indicates a true positive bait-prey interaction. White color indicates the absence of a baitprey interaction.
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3.3 Retransformation and Screening of Mulan30-240 Interactors

The Mulan BAM domain interactors were then cloned from pJG4-5 vector taken from the
positive yeast, digested with EcoRI and XhoI, and ligated back into pJG4-5. Yeast cells were
then transformed with the newly synthesized preys and streaked onto U⁻H⁻W⁻ glucose + X-Gal
plates and U⁻H⁻W⁻ galactose/raffinose + X-Gal plates. Both interactors showed blue color
indicating a positive test, however, S100A10 showed an intense blue color whereas calumenin
showed a white color (figure 12).
The cDNA encoding full length S100A10 and calumenin were cloned into the pJG4-5
vector as described in chapter two. The pJG4-5 vector is under the control of the GAL1 promoter
which makes expression of the insert induced in the presence of galactose and repressed by the
presence of glucose. The pJG4-5 vector also allows for expression of a SV40 nuclear localization
sequence, B42 transcriptional activator, HA and S100A10 or CALU9 fusion proteins. HAS100A10 fusion protein has an estimated molecular weight of ≈ 22 kDa since the molecular
weight of S100A10 is ≈ 11.2 kDa and the molecular weight of the other peptides is ≈ 10.8 kDa
(Figure 13). HA-CALU9 fusion protein has an estimated molecular weight of ≈ 28.4 kDa since
the molecular weight of CALU9 is ≈ 17.6 kDa and the molecular weight of the other peptides is
≈ 10.8 kDa (Figure 13).
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Figure 12: Mulan BAM Interactors Retransformed into Yeast Screening

DNA corresponding to the full length cDNA sequence of Calumenin or S100A10 was cloned
into the pJG4-5 vector and retransformed into yeast carrying the LexA-Mulan30-240 bait. These
yeast were then grown on U⁻ H⁻ W⁻ galactose/raffinose/X-Gal screened for blue color. Bluecolored colonies indicate a positive interaction between the bait and prey proteins.
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Figure 13: Expression of pJG4-5-HA-S100A10/CALU in Yeast Cells

Western blot showing the expression of the HA-S100A10 and HA-CALU fusion proteins. Lane
1: HA-positive control. Lane 2: uninduced HA-S100A10. Lane 3: induced HA-S100A10. Lane 4:
uninduced HA-CALU. Lane 5: induced HA-CALU. Uninduced yeast were grown in U⁻H⁻W⁻
glucose media. Induced yeast cells were grown in U⁻H⁻W⁻ galactose/raffinose media.

45

3.4 Characterization of Mulan30-240 Interactors

The pJG4-5 plasmids containing the cDNA of the Mulan30-240 BAM domain interactors
were released from yeast cells and introduced into KC8 bacteria cells. The prey plasmids were
then purified and retransformed back into yeast to confirm the protein interaction. The prey
plasmids were also sent for DNA sequencing. The results of the DNA sequencing were analyzed
using the NCBI BLAST program (https://blast.ncbi.nlm.nih.gov/Blast.cgi). The identities of the
three Mulan30-240 BAM domain interactors were determined to be calumenin, S100A10, and
Cytochrome C Oxidase subunit II.
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NAME

Mulan30-240

Calumenin, isoform 9

+

S100A10

+

Cytochrome C Oxidase, subunit II

+

Table 1: List of Mulan BAM Domain Interactors Isolated from a HeLa cDNA Library

Positive protein-protein interactions are indicated by a (+) sign and negative protein-protein
interactions are indicated by a (-) sign.
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3.5 Characterization of Calumenin
Calumenin (CALU) is a member of the CREC family of Ca2+ binding proteins that have
multiple EF-hand domains (Honoré & Vorum, 2000). In addition to the 6 EF-hand domains, full
length calumenin (CALU1) contains a C-terminal 19 aa signal peptide, a N-terminal 4 aa ER/SR
retention signal, and a N-glycosylation site at aa 131 (D. H. Jung & Kim, 2004). CALU1 is
expressed ubiquitously with the greatest levels of the protein in the heart (Yabe, Nakamura,
Kanazawa, Tashiro, & Honjo, 1997). Expression of CALU1 decreases in adult tissue compared
to neonatal and embryonic mouse hearts until it reaches a steady state (Papp, Zhang, Szabo,
Michalak, & Opas, 2008; Sahoo et al., 2009). CALU1 functions in calcium homeostasis since its
overexpression increases Ca2+ storage capacity and decreases Ca2+ release (D. H. Jung, Mo, &
Kim, 2006). In addition to its role in Ca2+ homeostasis, CALU1 may also regulate γcarboxylation and thrombosis(Hansen, Vorum, Jacobsen, & Honoré, 2009; Wallin, 2001).
There are 15 isoforms of calumenin and our screening isolated isoform 9. Different
isoforms have the potential to have different localizations and functions. Labeling each isoform
with GFP revealed that CALU9, CALU12, and CALU15 localize significantly differently than
the other isoforms that are localized to the ER and Golgi apparatus for secretion. CALU15 is the
only isoform that localizes to the nucleus where it serves as a transcription factor (Feng et al.,
2013). CALU9 along with CALU12 and CALU15 are unique from all other isoforms because
they lack the N-glycosylation site.
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3.6 Characterization of S100A10
S100A10, also known as P11, is a member of the S100 family of calcium-binding
proteins which contain Ca2+-binding helix-loop-helix motif. However, S100A10 different from
the rest of the family since it has a permanent “calcium-on” state due to mutation. S100A10 is
expressed relatively ubiquitously except in the liver and erythrocytes. It is localized to the ER,
endosomes, and plasma membrane (Egeland, Warner-Schmidt, Greengard, & Svenningsson,
2010). S100A10 is typically found in bound to annexin A2 (p36) ligand as the heterotetrameric
(S100A10)2-(annexin A2)2 complex. This complex functions on the cell surface where it
promotes fibrinolysis by acting as an assembly site for plasmin. In the absence of annexin A2,
S100A10 is rapidly degraded by ubiquitin-mediated proteasome (Hedhli et al., 2012).
The S100A10 protein appears to have no physiological relationship to the Mulan BAM
domain that is located in the IMS of the mitochondria. While the S100A family is very diverse
and encoded across numerous genes, S100A10 appears to be closely related to a couple of other
S100A proteins, namely S100A1, S100A2, and S100A6. These proteins share a greater percent
identity to S100A10 and may be able to interact with the Mulan BAM domain. Our lab is
currently in the process of cloning the most similar family member, S100A1, into the pJG4-5
vector where it can be screened with the LexA-Mulan30-240 bait.
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S100A10
S100A1
S100A2
S100A3
S100A4
S100A5
S100A6
S100A7
S100A8
S100A9
S100A11
S100A12
S100A13
S100A14
S100A15
S100A16

Percentage Identity
100
49
37
29
37
33
30
29
29
32
40
35
28
31
29
27

Percentage Homology
100
72
61
52
60
62
59
51
55
59
61
62
51
58
51
57

Table 2: Identity and Homology of S100A Family Members to S100A10

The amino acid sequences of the S100A family of proteins was compared to the amino acid
sequence of S100A10 using the NCBI BLAST program.
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Figure 14: S100A1 and S100A10 Sequence Alignment

Comparison of the amino acid sequences of S100A1 and S100A10. Sequences aligned by Clustal
Omega and colored by Zappo and 40% conservation in Jalview.
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Table 3: Comparison of Mulan with S100A1 and S100A10

The tissue expression, subcellular localization, and known functions of Mulan, S100A1, and S100A10 are
summarized.
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CHAPTER FOUR: DISCUSSION

Mitochondrial dynamics describes the process of mitochondrial fusion and fission. Mfn1,
Mfn2, and Opa1 are key proteins related to fusion whereas Drp1 is critical for fission. The cycles
of fusion and fission result in daughter mitochondria with unequal distribution of mtDNA and
proteins. The daughter mitochondrion with lower quality mtDNA and proteins is depolarized and
exits the cycle of mitochondrial dynamics (Dorn & Kitsis, 2014). Depolarized mitochondria can
signal the initiation of mitophagy or apoptosis (Priault et al., 2005). Mitophagy is the process by
which an autophagosome surrounds the mitochondrion and fuses with a lysosome which
proceeds to degrade the contents of the autophagosome. Mitophagy protects the quality of
mitochondria population in a cell (Elmore et al., 2001). If a stress is too much for the cells to
handle, controlled cell death is initiated through the intrinsic pathway of apoptosis. The
mitochondria permeabilizes and releases proapoptotic factors which activate caspases that
proceed to degrade the contents in the cell (Chipuk et al., 2010). Mitochondrial calcium is a key
regulator of apoptosis and is thought to also participate in mitophagy (Calì et al., 2013; Heeman
et al., 2011; Sandebring et al., 2009).
Mulan is an E3 ubiquitin and E3 SUMO ligase embedded in the OMM. The RING finger
domain of Mulan faces the cytosol and is responsible for the E3 ligase activity. Using its E3
ligase activity, Mulan is known to play a role in mitochondrial dynamics, mitophagy, and
apoptosis. Mulan overexpression promotes mitochondrial fragmentation, Ca2+ flux, and
apoptosis (Braschi et al., 2009; Neuspiel et al., 2008; B. Zhang et al., 2008). While the RING
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finger of Mulan has been well characterized, little work has been done to characterize the BAM
domain of Mulan that is located in the IMS.
Using the BAM domain of Mulan as a bait in a yeast two-hybrid screen of a HeLa cDNA
library, three potential protein interactors were isolated. These were determined to be Calumenin
isoform 9, S100A10, and cytochrome c oxidase, subunit 2. Cloning of the full length versions of
S100A10 and CALU9 into pJG4-5 confirmed a bona fide protein-protein interaction with the
BAM domain of Mulan.
Calumenin isoform 1 is the best characterized isoform out of the 15 total isoforms (Feng
et al., 2013). CALU1 is expressed ubiquitously with the highest levels found in the heart (Yabe
et al., 1997). It is localized to the ER and Golgi apparatus, and is also secreted. Six EF-hand
domains allow CALU1 to bind many molecules of calcium and the function of CALU1 includes
promotion of Ca2+ storage in the ER, inhibition of Ca2+ release from the ER, and promotion of
thrombosis when secreted (Hansen et al., 2009; D. H. Jung & Kim, 2004).
While knowledge of the functions of CALU1 can suggest possible functions of CALU9,
different isoforms have distinct subcellular localization and functions (Feng et al., 2013). The
significance of this difference has yet to be investigated. Future work should focus on whether
CALU9 is localized to the mitochondria and whether the interaction with the BAM domain of
Mulan is physiologically relevant.
S100A10 is also a well characterized protein and shares a family with over 15 other S100
proteins. It is expressed almost ubiquitously and is also localized to the ER and Golgi apparatus
as well as endosomes. S100A10 is unique from others S100 proteins because it has a Ca2+54

binding helix-loop-helix motif that is in a permanent “Ca2+ on” state. S100A10 is most
commonly found associated with annexin A2 on the cell surface where they serve as a platform
for plasmin assembly.
Given the knowledge of its functions and localization, S100A10 may not be a
physiologically relevant interactor of the BAM domain of Mulan that is confined to the IMS of
mitochondria. However, a comparison of S100A10 with other proteins in its family revealed
S100A10 to have significantly higher percentage identity with S100A1 than any other family
member.
S100A1 is expressed most highly in the heart, but is also found in skeletal muscle,
kidney, and brain tissue (Kato & Kimura, 1985). Immunocytochemical localization of S100A1
revealed the protein resides within the mitochondria and the OMM (Brezová, Heizmann, &
Uhrík, 2007; Donato et al., 1989). Within the mitochondria, S100A1 activates the F1-ATPase, or
complex V of the ETC, to increase ATP levels (Boerries et al., 2007). The activity of S100A1 is
dependent on its ability to bind calcium (Wright et al., 2005). Furthermore, the ability of S100A1
to bind calcium is greatly affected by S-Glutathionylation and S-nitrosylation at Cysteine 85.
Therefore, S100A1 is sensitive to the nitric oxide (NO) and the redox status of the cell (Goch,
Vdovenko, Kozłowska, & Bierzyñski, 2005; Zhukova, Zhukov, Bal, & Wyslouch-Cieszynska,
2004). Cysteine 85 and the amino acids on either side are conserved between S100A1 and
S100A10. Myocardial cells lacking S100A1 showed decreased ATP synthase activity and ATP
levels. Reconstituting S100A1 into such cells using adenovirus prevented ∆Ψm depolarization
and OMM permeabilization under normal and excess Ca2+ conditions thus reversing signs of
heart failure (Brinks et al., 2011; Most et al., 2004).
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Future work should focus on whether S100A1 can also interact with the BAM domain of
Mulan and how that interaction affects the functions of both Mulan and S100A1.
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